Why MediQ7®
Clinically Proven Superior Absorption, UltraShield™ Technology
The absorption and bioavailability of Vitamin K2 MK-7 can vary significantly depending on the formulation technology, even when the same raw material is used.
MediQ7® is formulated with GF Fermentech’s proprietary UltraShield™ technology to maximize absorption and bioavailability in the body. In a human clinical study, MediQ7® demonstrated approximately three times higher absorption compared to conventional powder-type MK-7. It also showed significant improvements across key pharmacokinetic parameters, including total absorption (AUC), maximum plasma concentration (Cmax), and time to reach maximum concentration (Tmax).
More than simply supplying Vitamin K2, MediQ7® is a next-generation Vitamin K2 solution designed to ensure more efficient absorption and utilization within the body.
- Study subjects: 23 healthy adults (aged 20–29 years)
- Study period: Blood samples collected up to 72 hours after a single dose
- Dose: One capsule containing 420 μg of vitamin K2 (MK-7)
- Evaluation marker: Plasma MK-7 concentration
- Outcome measures: Area under the concentration–time curve (AUC), maximum plasma concentration (Cmax), time to reach maximum concentration (Tmax)